Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
epilepsy
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
blackstone group
boston
david goldstein
depression
essential tremor
fda
kiran reddy
major depressive disorder
nonalcoholic steatohepatitis
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
startups
steven petrou
3b pharmaceuticals
abeona therapeutics
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
aligos therapeutics
alkermes
allan kaspar
altria
amgen
amphivena therapeutics
amryt pharma
andrew komjathy
antisense oligonucleotide
What
drugs
medicines
praxis
precision
research
according
aims
akcea
backed
biotech
biotechs
cases
cause
centers
central
ceo
cigarettes
cns
control
deaths
disease
disorder
electronic
emerged
epilepsy
genes
genetic
including
injuries
ipos
kept
leads
linked
links
lung
marcio
mutations
nash
nervous
neuro
Language
unset
Current search:
epilepsy
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More